Hisashi Wada

7.2k total citations · 2 hit papers
103 papers, 4.3k citations indexed

About

Hisashi Wada is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Hisashi Wada has authored 103 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Immunology, 45 papers in Oncology and 31 papers in Molecular Biology. Recurrent topics in Hisashi Wada's work include Immunotherapy and Immune Responses (43 papers), Immune Cell Function and Interaction (32 papers) and Cancer Immunotherapy and Biomarkers (31 papers). Hisashi Wada is often cited by papers focused on Immunotherapy and Immune Responses (43 papers), Immune Cell Function and Interaction (32 papers) and Cancer Immunotherapy and Biomarkers (31 papers). Hisashi Wada collaborates with scholars based in Japan, United States and Australia. Hisashi Wada's co-authors include Lloyd J. Old, Yuji Noguchi, Michael W. Marino, Ashley R. Dunn, Alexander Knuth, Michael Arand, Elisabeth Stockert, Julia Karbach, Elke Jäger and Yuichiro� Doki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Hisashi Wada

95 papers receiving 4.3k citations

Hit Papers

Characterization of tumor necrosis factor-deficient mice 1997 2026 2006 2016 1997 1998 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Characterization of tumor necrosis factor-deficient mice
    1997 675 citations Michael W. Marino, Yuji Noguchi et al. profile →
  2. Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes
    1998 594 citations Hisashi Wada, Yuji Noguchi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hisashi Wada Japan 31 2.7k 1.6k 1.5k 428 411 103 4.3k
Maria Raffaella Zocchi Italy 45 3.8k 1.4× 1.4k 0.9× 1.6k 1.0× 291 0.7× 197 0.5× 152 6.0k
Jason A. Hackney United States 29 2.1k 0.8× 1.2k 0.7× 1.7k 1.1× 358 0.8× 194 0.5× 45 4.7k
Yasuharu Nishimura Japan 44 3.0k 1.1× 1.8k 1.1× 2.6k 1.7× 335 0.8× 302 0.7× 171 6.0k
Camilla Jandus Switzerland 34 3.3k 1.2× 1.4k 0.9× 1.6k 1.0× 415 1.0× 156 0.4× 82 4.7k
Djordje Atanackovic Germany 43 2.1k 0.8× 2.1k 1.3× 1.6k 1.0× 175 0.4× 414 1.0× 142 4.4k
Clemens Scheinecker Austria 37 3.2k 1.2× 1.0k 0.6× 1.6k 1.0× 234 0.5× 152 0.4× 64 5.6k
Mikael C. I. Karlsson Sweden 39 3.4k 1.2× 1.1k 0.7× 1.9k 1.3× 207 0.5× 276 0.7× 104 5.4k
Lei Ding China 31 1.9k 0.7× 998 0.6× 2.1k 1.3× 268 0.6× 409 1.0× 89 5.9k
John M. Herndon United States 26 2.6k 1.0× 1.5k 1.0× 1.2k 0.8× 164 0.4× 216 0.5× 44 4.2k

Countries citing papers authored by Hisashi Wada

Since Specialization
Citations

This map shows the geographic impact of Hisashi Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hisashi Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hisashi Wada more than expected).

Fields of papers citing papers by Hisashi Wada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hisashi Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hisashi Wada. The network helps show where Hisashi Wada may publish in the future.

Co-authorship network of co-authors of Hisashi Wada

This figure shows the co-authorship network connecting the top 25 collaborators of Hisashi Wada. A scholar is included among the top collaborators of Hisashi Wada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hisashi Wada. Hisashi Wada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Noda, Takehiro, Shogo Kobayashi, Chihiro Yamanaka, et al.. (2025). Tumor Endothelial Cells Induce M2 Macrophage Polarization via IL ‐4, Enhancing Tumor Growth in Hepatocellular Carcinoma. Cancer Science. 116(11). 2972–2985.
2.
Hayashi, Yoshinori, Takuro Saito, Atsunari Kawashima, et al.. (2025). The immunosuppressive role of CCR8 + Tregs in gastric cancer. Journal of Cancer. 16(15). 4390–4399.
3.
Saito, Takuro, et al.. (2025). Impact of oral anaerobic bacteria on the tumor immune microenvironment and prognosis of oral cancer. Journal of Translational Medicine. 23(1). 1267–1267.
4.
Tone, Mari, Kota Iwahori, Michinari Hirata, et al.. (2024). Tetracyclines enhance antitumor T-cell immunity via the Zap70 signaling pathway. Journal for ImmunoTherapy of Cancer. 12(4). e008334–e008334. 6 indexed citations
5.
Saito, Takuro, Yukinori Kurokawa, Kazumasa Fujitani, et al.. (2024). Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study. British Journal of Cancer. 130(7). 1157–1165. 3 indexed citations
6.
Kawakami, Hisato, Daichi Maeda, Daisuke Sakai, et al.. (2023). The potential clinical utility of cell-free DNA for gastric cancer patients treated with nivolumab monotherapy. Scientific Reports. 13(1). 5652–5652. 2 indexed citations
7.
Kawada, Junji, Takuro Saito, Yukinori Kurokawa, et al.. (2023). Serum NY‐ESO‐1 and p53 antibodies as useful tumor markers in gastric cancer. Annals of Gastroenterological Surgery. 8(2). 243–250. 2 indexed citations
8.
Nagira, Morio, Ryohei Nagai, Michinari Hirata, et al.. (2023). S-531011, a Novel Anti-Human CCR8 Antibody, Induces Potent Antitumor Responses through Depletion of Tumor-Infiltrating CCR8-Expressing Regulatory T Cells. Molecular Cancer Therapeutics. 22(9). 1063–1072. 14 indexed citations
9.
Hayashi, Yoshinori, Tomoki Makino, Eiichi Sato, et al.. (2023). Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors. British Journal of Cancer. 128(12). 2175–2185. 55 indexed citations
10.
Jingushi, Kentaro, Atsunari Kawashima, Takuro Saito, et al.. (2022). Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients. Cancer Immunology Immunotherapy. 71(12). 2999–3011. 10 indexed citations
11.
Hirata, Michinari, Miya Haruna, Azumi Ueyama, et al.. (2022). Tumor-infiltrating ICOS+Effector Regulatory T-Cells in Oral Squamous Cell Carcinoma as a Promising Biomarker for Prognosis and ‘Hot’ Tumor. Anticancer Research. 42(5). 2383–2393.
12.
Maeda, Yuka, Hisashi Wada, Daisuke Sugiyama, et al.. (2021). Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab. Nature Communications. 12(1). 7280–7280. 29 indexed citations
13.
Kojo, Satoshi, et al.. (2020). Constitutive CD8 expression drives innate CD8+ T-cell differentiation via induction of iNKT2 cells. Life Science Alliance. 3(2). e202000642–e202000642. 7 indexed citations
14.
Kurose, Koji, Yoshihiro Ohue, Hisashi Wada, et al.. (2015). Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients. Clinical Cancer Research. 21(19). 4327–4336. 179 indexed citations
15.
Aoki, Masatoshi, Shugo Ueda, Hiroyoshi Nishikawa, et al.. (2009). Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432. Vaccine. 27(49). 6854–6861. 43 indexed citations
16.
Kawabata, Ryohei, Hisashi Wada, Midori Isobe, et al.. (2007). Antibody response against NY‐ESO‐1 in CHP‐NY‐ESO‐1 vaccinated patients. International Journal of Cancer. 120(10). 2178–2184. 58 indexed citations
17.
18.
Noguchi, Yuji, Hisashi Wada, Michael W. Marino, & Lloyd J. Old. (1998). Regulation of IFN-γ production in granulocyte-macrophage colony-stimulating factor-deficient mice. European Journal of Immunology. 28(12). 3980–3988. 17 indexed citations
19.
Yasuda, Tadashi, Yo Sasaki, Shingi Imaoka, et al.. (1990). Comparative study of portal hemodynamics and regional hepatic blood flow before and after hepatic resection by 133Xe-scintiphotosplenoportography.. The Japanese Journal of Gastroenterological Surgery. 23(7). 1838–1841. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Raffaella Zocchi Breakdown of academic impact, for papers by Jason A. Hackney Breakdown of academic impact, for papers by Yasuharu Nishimura Breakdown of academic impact, for papers by Camilla Jandus Breakdown of academic impact, for papers by Djordje Atanackovic Breakdown of academic impact, for papers by Clemens Scheinecker Breakdown of academic impact, for papers by Mikael C. I. Karlsson Breakdown of academic impact, for papers by Lei Ding Breakdown of academic impact, for papers by John M. Herndon
Rankless by CCL
2026